ZAVESCA

Serial Number 85185312
Registration 4089805
800

Registration Progress

Application Filed
Nov 25, 2010
Under Examination
Approved for Publication
Nov 8, 2011
Published for Opposition
Nov 8, 2011
Registered
Jan 24, 2012

Trademark Image

ZAVESCA

Basic Information

Serial Number
85185312
Registration Number
4089805
Filing Date
November 25, 2010
Registration Date
January 24, 2012
Published for Opposition
November 8, 2011
Renewal Date
January 24, 2022
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
May 5, 2022
Registration
Registered
Classes
005

Rights Holder

Actelion Pharmaceuticals Ltd.

03
Address
Gewerbestrasse 16
Allschwil CH-4123
CH

Ownership History

Actelion Pharmaceuticals Ltd.

Original Applicant
03
Allschwil CH

Actelion Pharmaceuticals Ltd.

Owner at Publication
03
Allschwil CH

Actelion Pharmaceuticals Ltd.

Original Registrant
03
Allschwil CH

Legal Representation

Attorney
Cheryl Foytlin

USPTO Deadlines

Next Deadline
2371 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2012-01-24)
Due Date
January 24, 2032
Grace Period Ends
July 24, 2032

Application History

34 events
Date Code Type Description Documents
May 5, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 5, 2022 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
May 5, 2022 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
May 5, 2022 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jan 6, 2022 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 24, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Mar 6, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 6, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 20, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 20, 2018 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 20, 2018 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Dec 27, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 24, 2017 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 24, 2012 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 8, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 8, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 6, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 30, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 30, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 30, 2011 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 23, 2011 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 23, 2011 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 8, 2011 CNRT O NON-FINAL ACTION MAILED Loading...
Jul 7, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 8, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 8, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 24, 2011 ALIE A ASSIGNED TO LIE Loading...
May 17, 2011 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 14, 2011 CNRT F NON-FINAL ACTION MAILED Loading...
Mar 13, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 4, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 2, 2010 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Dec 1, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 29, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treating glycolipid storage diseases, including Gaucher's disease and Niemann-Pick type C disease
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the word "ZAVESCA" in stylized letters with a series of ellipses.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "ZAVESCA" has no meaning in a foreign language.

Classification

International Classes
005